Effects of protein modification procedures on the interaction between 25-hydroxyvitamin D and the human plasma binding protein for vitamin D and its metabolites.
D015652:25-Hydroxyvitamin D 2; D001120:Arginine / Q000378:metabolism; D002352:Carrier Proteins / Q000378:metabolism*; D004872:Ergocalciferols / Q000031:analogs & derivatives* / Q000378:metabolism; D019791:Guanidine; D006146:Guanidines / Q000494:pharmacology; D006801:Humans; D008239:Lysine / Q000378:metabolism; D008745:Methylation; D013056:Spectrophotometry, Ultraviolet; D013329:Structure-Activity Relationship; D014807:Vitamin D / Q000378:metabolism*; D014809:Vitamin D-Binding Protein
D002352:Carrier Proteins; D004872:Ergocalciferols; D006146:Guanidines; D014809:Vitamin D-Binding Protein; D014807:Vitamin D; D015652:25-Hydroxyvitamin D 2; D001120:Arginine; D019791:Guanidine; D008239:Lysine